Stocks
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA, bln rub | ? | 45.0 | 9.06 | -10.9 | -32.5 | -126.7 | -143.3 | |
| Changes by years, y/y, % | +30% | -80% | -221% | +197% | +290% | |||
Vanda Pharmaceuticals. EBITDA US GAAP, bln rub
Vanda Pharmaceuticals. EBITDA US GAAP, changes, %
Vanda Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -26.3 | -32.1 | -44.9 | -65.9 | -63.2 | -143.3 | |
| Changes by years, y/y, % | +192% | +287% | +44% | +101% | +92% | |||
| Changes by quarters, q/q, % | -20% | +22% | +40% | +47% | -4% | |||
